Last quarter (Q3 2025), IDEAYA Biosciences's total revenue was $207.83M, an increase of 2869.06% from the same quarter last year. In Q3, IDEAYA Biosciences's net income was $119.24M. See IDEAYA Biosciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 7.00M	$ 23.39M	$ 50.93M	$ 27.94M	$ 19.54M
Gross Profit	$ 3.17M	$ 19.38M	$ 48.83M	$ 26.22M	$ 18.16M
Operating Expenses	$ 330.14M	$ 153.81M	$ 111.33M	$ 76.48M	$ 53.50M
Depreciation and Amortization	$ 3.83M	$ 4.01M	$ 2.10M	$ 1.73M	$ 1.38M
EBITDA	$ -270.64M	$ -108.95M	$ -56.55M	$ -48.04M	$ -33.11M
Operating Income	$ -326.98M	$ -134.43M	$ -62.50M	$ -50.27M	$ -35.34M
Other Income/Expenses	$ 52.50M	$ 21.47M	$ 3.85M	$ 506.00K	$ 849.00K
Pretax Income	$ -274.48M	$ -112.96M	$ -58.66M	$ -49.76M	$ -34.49M
Net Income	$ -274.48M	$ -112.96M	$ -58.66M	$ -49.76M	$ -34.49M
Per Share Metrics
Basic EPS	$ -3.36	$ -1.96	$ -1.42	$ -1.41	$ -1.31
Diluted EPS	$ -3.36	$ -1.96	$ -1.42	$ -1.41	$ -1.31
Weighted Average Shares Outstanding	81.68M	57.52M	41.44M	35.25M	24.72M
Weighted Average Shares Outstanding (Diluted)	81.68M	57.52M	41.44M	35.25M	24.72M

Currency in USD

IDEAYA Biosciences Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing